DK1337529T3 - Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem - Google Patents

Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem

Info

Publication number
DK1337529T3
DK1337529T3 DK01996538T DK01996538T DK1337529T3 DK 1337529 T3 DK1337529 T3 DK 1337529T3 DK 01996538 T DK01996538 T DK 01996538T DK 01996538 T DK01996538 T DK 01996538T DK 1337529 T3 DK1337529 T3 DK 1337529T3
Authority
DK
Denmark
Prior art keywords
preparation
preparations containing
heterocyclylalkylpiperidine derivatives
heterocyclylalkylpiperidine
derivatives
Prior art date
Application number
DK01996538T
Other languages
English (en)
Inventor
Philippe Hubert
Eric Bacqu
Jean-Christophe Carry
Youssef El-Ahmad
Michel Evers
Jean-Luc Malleron
Serge Mignani
Guy Pantel
Michel Tabart
Fabrice Viviani
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Application granted granted Critical
Publication of DK1337529T3 publication Critical patent/DK1337529T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK01996538T 2000-11-15 2001-11-14 Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem DK1337529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
DK1337529T3 true DK1337529T3 (da) 2006-12-18

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996538T DK1337529T3 (da) 2000-11-15 2001-11-14 Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem

Country Status (28)

Country Link
EP (2) EP1337529B1 (da)
JP (1) JP2004514661A (da)
KR (1) KR100849608B1 (da)
CN (1) CN1483031A (da)
AR (1) AR034006A1 (da)
AT (1) ATE337311T1 (da)
AU (2) AU1836502A (da)
BG (1) BG107793A (da)
BR (1) BR0115312A (da)
CA (1) CA2429311A1 (da)
CZ (1) CZ20031316A3 (da)
DE (1) DE60122567T2 (da)
DK (1) DK1337529T3 (da)
EA (1) EA200300568A1 (da)
EE (1) EE200300207A (da)
ES (1) ES2271119T3 (da)
FR (1) FR2816618B1 (da)
HR (1) HRP20030379A2 (da)
HU (1) HUP0303758A3 (da)
IL (1) IL155841A0 (da)
NO (2) NO20032187L (da)
PL (1) PL363004A1 (da)
PT (1) PT1337529E (da)
SK (1) SK5822003A3 (da)
TN (1) TNSN01160A1 (da)
WO (1) WO2002040474A2 (da)
YU (1) YU46803A (da)
ZA (1) ZA200303794B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
EP1567520B1 (en) 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
CN101166730A (zh) 2005-03-01 2008-04-23 惠氏公司 噌啉化合物及其作为肝x受体调节剂的用途
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ES2376488T3 (es) 2006-01-26 2012-03-14 Actelion Pharmaceuticals Ltd. Antibióticos de tetrahidropirano.
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AR067008A1 (es) 2007-06-15 2009-09-30 Actelion Pharmaceuticals Ltd Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
CN107163038B (zh) * 2012-08-15 2020-07-28 葛兰素集团有限公司 化学方法
SG11201700566SA (en) 2014-08-22 2017-03-30 Glaxosmithkline Ip Dev Ltd Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20072142L (no) 2007-04-25
AU2002218365B2 (en) 2007-07-05
TNSN01160A1 (fr) 2005-11-10
EP1337529B1 (fr) 2006-08-23
IL155841A0 (en) 2003-12-23
SK5822003A3 (en) 2004-06-08
CZ20031316A3 (cs) 2003-10-15
EP1337529A2 (fr) 2003-08-27
ATE337311T1 (de) 2006-09-15
FR2816618B1 (fr) 2002-12-27
FR2816618A1 (fr) 2002-05-17
ZA200303794B (en) 2004-06-29
EA200300568A1 (ru) 2003-12-25
JP2004514661A (ja) 2004-05-20
CA2429311A1 (en) 2002-05-23
KR100849608B1 (ko) 2008-07-31
ES2271119T3 (es) 2007-04-16
WO2002040474A3 (fr) 2002-10-31
AU1836502A (en) 2002-05-27
HRP20030379A2 (en) 2005-04-30
BR0115312A (pt) 2003-09-23
NO20032187L (no) 2003-06-26
EE200300207A (et) 2003-08-15
PL363004A1 (en) 2004-11-15
DE60122567D1 (de) 2006-10-05
AR034006A1 (es) 2004-01-21
EP1695964A1 (fr) 2006-08-30
BG107793A (bg) 2004-08-31
PT1337529E (pt) 2006-12-29
WO2002040474A2 (fr) 2002-05-23
HUP0303758A3 (en) 2009-08-28
HUP0303758A2 (hu) 2004-03-01
KR20030060934A (ko) 2003-07-16
CN1483031A (zh) 2004-03-17
NO20032187D0 (no) 2003-05-14
YU46803A (sh) 2006-05-25
DE60122567T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
DK1337529T3 (da) Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem
DK1370550T3 (da) Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
DK1228039T3 (da) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater, der omfatter dem
DK1210348T3 (da) Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20010469L (no) Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende dem
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse